Navasota Resources Inc.

Healthcare CA NAV

0.005CAD
0.00(0%)

Last update at 2026-06-19T13:30:00Z

Day Range

0.0050.005

LowHigh

52 Week Range

0.0050.01

LowHigh

Fundamentals

Previous Close 0.005
Market Cap0.57M
Volume10412
P/E Ratio-
Dividend Yield-%
EBITDA-0.01922M
Revenue TTM0.00520M
Revenue Per Share TTM-
Gross Profit TTM 0.06M
Diluted EPS TTM-0.06

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2022-09-30	2021-09-30
Type	yearly	yearly
Date	2022-09-30	2021-09-30
Income before tax	-0.09368M	-0.07408M
Minority interest	-	-
Net income	-0.09368M	-0.07408M
Selling general administrative	0.07M	0.06M
Selling and marketing expenses	-	-
Gross profit	-	-
Reconciled depreciation	-	-
Ebit	-	-
Ebitda	-	-
Depreciation and amortization	-	-
Non operating income net other	-	-
Operating income	-0.10009M	-0.07954M
Other operating expenses	-	-
Interest expense	-	-
Tax provision	-	-
Interest income	0.00641M	0.00546M
Net interest income	0.00641M	0.00546M
Extraordinary items	-	-
Non recurring	-	-
Other items	-	-
Income tax expense	-	-
Total revenue	0.00000M	0.00000M
Total operating expenses	0.10M	0.08M
Cost of revenue	-	-
Total other income expense net	-	-
Discontinued operations	-	-
Net income from continuing ops	-0.09368M	-0.07408M
Net income applicable to common shares	-	-
Preferred stock and other adjustments	-	-

Breakdown	2022-09-30	2021-09-30
Type	yearly	yearly
Date	2022-09-30	2021-09-30
Total assets	0.11M	0.12M
Intangible assets	-	-
Earning assets	-	-
Other current assets	-	-
Total liab	0.11M	0.02M
Total stockholder equity	0.00347M	0.10M
Deferred long term liab	-	-
Other current liab	-	-
Common stock	-	-
Capital stock	0.32M	0.32M
Retained earnings	-0.40210M	-0.30842M
Other liab	-	-
Good will	-	-
Other assets	-	-
Cash	0.00180M	0.01M
Cash and equivalents	-	-
Total current liabilities	0.11M	0.02M
Current deferred revenue	-	-
Net debt	-	-
Short term debt	-	-
Short long term debt	-	-
Short long term debt total	-	-
Other stockholder equity	-	-
Property plant equipment	-	-
Total current assets	0.11M	0.12M
Long term investments	-	-
Net tangible assets	-	-
Short term investments	-	-
Net receivables	-	-
Long term debt	-	-
Inventory	-	-
Accounts payable	0.06M	0.01M
Total permanent equity	-	-
Noncontrolling interest in consolidated entity	-	-
Temporary equity redeemable noncontrolling interests	-	-
Accumulated other comprehensive income	-	-
Additional paid in capital	-	-
Common stock total equity	-	-
Preferred stock total equity	-	-
Retained earnings total equity	-	-
Treasury stock	-	-
Accumulated amortization	-	-
Non currrent assets other	-	-
Deferred long term asset charges	-	-
Non current assets total	0.00000M	0.00000M
Capital lease obligations	-	-
Long term debt total	-	-

Breakdown	2022-09-30	2021-09-30
Type	yearly	yearly
Date	2022-09-30	2021-09-30
Investments	-	-
Change to liabilities	-	-
Total cashflows from investing activities	-	-
Net borrowings	-	-
Total cash from financing activities	0.00000M	-0.08850M
Change to operating activities	-	-
Net income	-0.09368M	-0.07408M
Change in cash	-0.01027M	-0.16921M
Begin period cash flow	0.01M	0.18M
End period cash flow	0.00180M	0.01M
Total cash from operating activities	-0.01027M	-0.08071M
Issuance of capital stock	-	-
Depreciation	-	-
Other cashflows from investing activities	-	-
Dividends paid	-	-
Change to inventory	-	-
Change to account receivables	-	-
Sale purchase of stock	-	-
Other cashflows from financing activities	-	-
Change to netincome	-	-
Capital expenditures	0.00000M	0.00000M
Change receivables	-	-
Cash flows other operating	-	-
Exchange rate changes	-	-
Cash and cash equivalents changes	-	-
Change in working capital	0.09M	-0.00117M
Stock based compensation	-	-
Other non cash items	-0.00641M	-0.00546M
Free cash flow	-0.01027M	-0.08071M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company	Change (CAD)	Price (CAD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)
NAV Navasota Resources Inc.	- -%	0.005	-	-	2.47	-	14.28
RX Biosyent Inc.	0.05 0.36%	14.00	19.10	15.85	3.96	4.11	3.31	11.03
DB Decibel Cannabis Company Inc	- -%	0.12	-	8.67	0.67	1.20	0.99	17.75
ZYUS ZYUS Life Sciences Corporation	- -%	0.50	-	-	108.48	4.41	140.29	-4.258
LSL LSL Pharma Group Inc.	0.005 1.59%	0.32	20.75	-	1.88	1.89	2.85	10.19

Reports Covered

View All

Profile

NAVCO Pharmaceuticals Inc. develops and commercializes supplemental and therapeutic consumer health and wellness products in the areas of antibacterial and immunity support and infectious disease prevention in Canada. The company offers aerosol sprays, hand cleansers, hand creams, and nano bioguard; and disinfectant spray products. It also provides diagnostic testing, textile, PPE, and food solutions. Its products are used in medicine, textiles, chemicals, and additives industries to combat microorganisms. NAVCO Pharmaceuticals Inc. is headquartered in Vancouver, Canada.

Navasota Resources Inc.

1170 ? 1040 West Georgia Street, Vancouver, BC, Canada, V6E 4H1

https://navcopharma.com

Key Executives

Name	Title	Year Born
Mr. Geoffrey Lee	Chief Executive Officer	NA
Mr. Christopher R. Cooper	Chief Financial Officer	1971
Mr. Marek Jasinski	COO & Director	1977
Mr. Thomas Jusdanis	Corporate Secretary & Independent Director	1958

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.